Bumetanide Injection, Solution
Product Images NDC 72572-211

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Bumetanide (NDC 72572-211). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Civica, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Structural Formula (Bum03 0001 01)

Chemical structure of bumetanide showing its aromatic ring with carboxyl, sulfonamide, alkoxy, and butyl amino substituents.*

FDA Label Image

Package Label – Principal Display Panel – Vial Label (Bum03 0001 02)

Label for Bumetanide Injection, USP, 1 mg per 4 mL (0.25 mg per mL) solution for injection. The vial is single-dose, 4 mL, for intravenous or intramuscular use, containing benzyl alcohol as a preservative. Distributed by Civica, Inc., made in India for Sagent Pharmaceuticals.*

FDA Label Image

Package Label – Principal Display Panel – Carton Label (Bum03 0001 03)

The image shows a carton label for Bumetanide Injection, USP 1 mg per 4 mL (0.25 mg per mL) by Civica, Inc. It is an injection solution for intravenous or intramuscular use containing benzyl alcohol. The package includes 10 vials of 4 mL single-dose each. The label details storage instructions, ingredients, and usual dosage information.*

FDA Label Image

Package Label – Principal Display Panel – Vial Label (Bum03 0001 04)

Bumetanide Injection, USP 2.5 mg per 10 mL (0.25 mg per mL) solution for intravenous or intramuscular use. The label indicates a 10 mL multi-dose vial containing benzyl alcohol as a preservative. Distributed by Civica, Inc. and manufactured for Sagent Pharmaceuticals in India. Includes NDC 72572-211-01 and storage instructions.*

FDA Label Image

Package Label – Principal Display Panel – Carton Label (Bum03 0001 05)

Packaging label for Bumetanide Injection, USP 2.5 mg per 10 mL (0.25 mg per mL) solution for injection. The label indicates the product is for intravenous or intramuscular use and contains benzyl alcohol. The product comes in a carton containing 10 x 10 mL multi-dose vials. Labeler is Civica, Inc. The label includes a barcode, drug details, storage instructions, and manufacturer information.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.